From: The burden of hip and knee osteoarthritis in Finnish occupational healthcare
ATC code | Medication | OA visits | All visits | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hip OA | Knee OA | Hip/Knee OA | Hip OA | Knee OA | Hip/Knee OA | Controls | p-value | fold change | |||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | ||||
M01AH05 | etoricoxib | 1450 | 22.6% | 6215 | 21.7% | 7665 | 21.8% | 3352 | 52.2% | 15,166 | 52.9% | 18,518 | 52.7% | 6118 | 17.4% | < 0.001 | 3.0 |
M01AE01 | ibuprofen | 815 | 12.7% | 3741 | 13.0% | 4556 | 13.0% | 3264 | 50.9% | 15,172 | 52.9% | 18,436 | 52.5% | 9741 | 27.8% | < 0.001 | 1.9 |
N02BE01 | paracetamol | 1228 | 19.1% | 4396 | 15.3% | 5624 | 16.0% | 3233 | 50.4% | 13,749 | 47.9% | 16,982 | 48.4% | 6644 | 18.9% | < 0.001 | 2.6 |
M01AB05 | diclofenac | 420 | 6.6% | 1671 | 5.8% | 2091 | 6.0% | 1845 | 28.8% | 8152 | 28.4% | 9997 | 28.5% | 4201 | 12.0% | < 0.001 | 2.4 |
M03BX02 | tizanidine | 190 | 3.0% | 452 | 1.6% | 642 | 1.8% | 1841 | 28.7% | 7846 | 27.3% | 9687 | 27.6% | 5070 | 14.4% | < 0.001 | 1.9 |
M01AX25 | chondroitin sulfate | 723 | 11.3% | 4137 | 14.4% | 4860 | 13.8% | 1252 | 19.5% | 6841 | 23.8% | 8093 | 23.1% | 352 | 1.0% | < 0.001 | 23.0 |
N02AJ06 | codeine & paracetamol | 434 | 6.8% | 1255 | 4.4% | 1689 | 4.8% | 1363 | 21.2% | 5498 | 19.2% | 6861 | 19.5% | 2631 | 7.5% | < 0.001 | 2.6 |
M01AE02 | naproxen | 240 | 3.7% | 987 | 3.4% | 1227 | 3.5% | 1128 | 17.6% | 5297 | 18.5% | 6425 | 18.3% | 2789 | 8.0% | < 0.001 | 2.3 |
N02AA59 | codeine, combinations | 279 | 4.4% | 819 | 2.9% | 1098 | 3.1% | 1155 | 18.0% | 4835 | 16.9% | 5990 | 17.1% | 2017 | 5.8% | < 0.001 | 3.0 |
M01AX05 | glucosamine | 447 | 7.0% | 2488 | 8.7% | 2935 | 8.4% | 895 | 14.0% | 4884 | 17.0% | 5779 | 16.5% | 374 | 1.1% | < 0.001 | 15.5 |
M02AA15 | diclofenac, topical | 112 | 1.8% | 815 | 2.8% | 927 | 2.6% | 801 | 12.5% | 4269 | 14.9% | 5070 | 14.4% | 1624 | 4.6% | < 0.001 | 3.1 |
M01AC06 | meloxicam | 196 | 3.1% | 1001 | 3.5% | 1197 | 3.4% | 796 | 12.4% | 3662 | 12.8% | 4458 | 12.7% | 1206 | 3.4% | < 0.001 | 3.7 |
M01AE52 | naproxen & esomeprazole | 234 | 3.7% | 809 | 2.8% | 1043 | 3.0% | 673 | 10.5% | 2955 | 10.3% | 3628 | 10.3% | 1021 | 2.9% | < 0.001 | 3.6 |
N02AX02 | tramadol | 279 | 4.4% | 669 | 2.3% | 948 | 2.7% | 762 | 11.9% | 2803 | 9.8% | 3565 | 10.2% | 1043 | 3.0% | < 0.001 | 3.4 |
N06AA09 | amitriptyline | 97 | 1.5% | 305 | 1.1% | 402 | 1.2% | 581 | 9.1% | 2148 | 7.5% | 2729 | 7.8% | 1019 | 2.9% | < 0.001 | 2.7 |
M02AA07 | piroxicam | 32 | 0.5% | 270 | 0.9% | 302 | 0.9% | 344 | 5.4% | 1880 | 6.6% | 2224 | 6.3% | 733 | 2.1% | < 0.001 | 3.0 |
N03AX16 | pregabalin | 62 | 1.0% | 171 | 0.6% | 233 | 0.7% | 336 | 5.2% | 1203 | 4.2% | 1539 | 4.4% | 573 | 1.6% | < 0.001 | 2.7 |
M01AH01 | celecoxib | 90 | 1.4% | 241 | 0.8% | 331 | 0.9% | 237 | 3.7% | 860 | 3.0% | 1097 | 3.1% | 236 | 0.7% | < 0.001 | 4.6 |
N03AX12 | gabapentin | 49 | 0.9% | 137 | 0.5% | 186 | 0.5% | 259 | 4.0% | 791 | 2.8% | 1050 | 3.0% | 349 | 1.0% | < 0.001 | 3.0 |
M09AX01 | hyaluronic acid, intra-articular | 29 | 0.5% | 648 | 2.3% | 677 | 1.9% | 53 | 0.8% | 980 | 3.4% | 1033 | 2.9% | 12 | 0.0% | < 0.001 | 86.1 |